Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
Study Details
Study Description
Brief Summary
This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
PRIMARY OBJECTIVE:
- To increase the number of smokers eligible for lung cancer screening (LCS) who receive high-quality educational materials about LCS through tobacco quitlines.
OUTLINE:
CALL CENTER STAFF: Participants undergo training consisting of a 60-minute educational session.
CALLERS SUBSTUDY: Participants are referred to lung cancer screening educational materials. Participants also complete questionnaires at 1 week and 6 months after referral to educational materials.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Call center staff (educational intervention) Participants undergo training consisting of a 60-minute educational session. |
Other: Educational Intervention
Undergo training consisting of a 60-minute educational session
Other Names:
Other: Survey Administration
Ancillary studies
|
Experimental: Callers substudy (LCS educational materials, questionnaire) Participants are referred to lung cancer screening educational materials. Participants also complete questionnaires at 1 week and 6 months after referral to educational materials. |
Other: Educational Intervention
Receive lung cancer screening educational materials
Other Names:
Other: Questionnaire Administration
Complete questionnaire
|
Outcome Measures
Primary Outcome Measures
- Content from communications (email, phone, monthly calls) [Up to 4 years]
Will be content analyzed using Atlas.ti qualitative software according to the adaptation framework from Stirman and colleagues. Will identify 1) who made the modification; 2) what was modified (i.e., content, context, training and evaluation); 3) for whom the modification was made (e.g., individual counselor); 4) context of the modification (e.g., format, setting, personnel, population); and 5) what was the nature of the modification (e.g., adding elements). Will also code for facilitators and barriers that are consistent with the constructs from CFIR. All textual data will be double coded and discussed by the researchers.
- Healthcare sector perspective [Up to 4 years]
As needed, will use a process-flow analysis to identify all resources utilized at each of the step of the program.
- Reach [During 6 month implementation period]
The analysis of the data from the logs and surveys will include examining the means, medians, standard deviations, and ranges overall and by state quitline for Reach
- Overall lung cancer screening rate [Up to 6 months]
- Effectiveness (Caller Substudy) [Up to 6 months]
Will be successful if callers who participate in the evaluation answer at least 58 percent (7/12) of the Adapted lung cancer screening (LCS)-12 Knowledge Measure questions correctly and have a PrepDM score of at least 80 (standard deviation [SD] = 17.7), which were observed in the original project.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
QUITLINE CALL CENTER STAFF
-
Staff member of a quitline
-
Aged 18 years and above
-
CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) INCLUSION CRITERIA
-
Callers 55-80 years of age
-
Current smoker, or former smoker with a cessation history of < 15 years
-
= 30 pack-year smoking history
-
English-speaking
Exclusion Criteria:
-
CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) EXCLUSION CRITERIA
-
History of lung cancer by self-report
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | M D Anderson Cancer Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Robert J Volk, M.D. Anderson Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 2020-0013
- NCI-2020-03812
- 2020-0013